Skip to main content Accessibility help
×
×
Home

Riboflavin status, MTHFR genotype and blood pressure: current evidence and implications for personalised nutrition

  • E. McAuley (a1), H. McNulty (a1), C. Hughes (a1), J. J. Strain (a1) and M. Ward (a1)...

Abstract

Clinical deficiency of the B-vitamin riboflavin (vitamin B2) is largely confined to developing countries; however accumulating evidence indicates that suboptimal riboflavin status is a widespread problem across the developed world. Few international data are available on riboflavin status as measured by the functional biomarker, erythrocyte glutathione reductase activation coefficient, considered to be the gold standard index. One important role of riboflavin in the form of flavin dinucleotide is as a co-factor for the folate-metabolising enzyme methylenetetrahydrofolate reductase (MTHFR). Homozygosity for the common C677T polymorphism in MTHFR, affecting over 10 % of the UK and Irish populations and up to 32 % of other populations worldwide, has been associated with an increased risk of CVD, and more recently with hypertension. This review will explore available studies reporting riboflavin status worldwide, the interaction of riboflavin with the MTHFR C677T polymorphism and the potential role of riboflavin in personalised nutrition. Evidence is accumulating for a novel role of riboflavin as an important modulator of blood pressure (BP) specifically in individuals with the MTHFR 677TT genotype, with results from a number of recent randomised controlled trials demonstrating that riboflavin supplementation can significantly reduce systolic BP by 5–13 mmHg in these genetically at risk adults. Studies are however required to investigate the BP-lowering effect of riboflavin in different populations and in response to doses higher than 1·6 mg/d. Furthermore, work focusing on the translation of this research to health professionals and patients is also required.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Riboflavin status, MTHFR genotype and blood pressure: current evidence and implications for personalised nutrition
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Riboflavin status, MTHFR genotype and blood pressure: current evidence and implications for personalised nutrition
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Riboflavin status, MTHFR genotype and blood pressure: current evidence and implications for personalised nutrition
      Available formats
      ×

Copyright

Corresponding author

* Corresponding author: Professor M. Ward, email mw.ward@ulster.ac.uk

References

Hide All
1. Food and Nutrition Board, Institute of Medicine (1998) Riboflavin. In Dietary Reference Intakes: Thiamin, Riboflavin, Niacin, Vitamin B6, Vitamin B12, Pantothenic Acid, Biotin, and Choline, pp. 87122 [Pitkin, RM, editor]. Washington, DC: National Academy Press.
2. Wilcken, B, Bamforth, F, Li, Z et al. (2003) Geographical and ethnic variation of the 677C→T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas worldwide. J Med Genet 40, 619625.
3. Klerk, M, Verhoef, P, Clarke, R et al. (2002) MTHFR 677C→T polymorphism and risk of coronary heart disease – a meta-analysis. JAMA 288, 20232031.
4. Yang, B, Fan, S, Zhi, X et al. (2014) Associations of MTHFR gene polymorphisms with hypertension and hypertension in pregnancy: a meta-analysis from 114 studies with 15411 cases and 21970 controls. PLoS ONE 9, e87497.
5. Horigan, G, McNulty, H, Ward, M et al. (2010) Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677C→T polymorphism in MTHFR. J Hypertens 28, 478486.
6. Wilson, CP, Ward, M, McNulty, H et al. (2012) Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up. Am J Clin Nutr 95, 766772.
7. Wilson, CP, McNulty, H, Ward, M et al. (2013) Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial. Hypertension 61, 13021308.
8. McCormick, DB (2006) Riboflavin. In Modern Nutrition in Health and Disease, 10th ed., pp. 391399 [Shils, ME, editor]. New York: Williams & Wilkins.
9. Powers, HJ (1999) Current knowledge concerning optimum nutritional status of riboflavin, niacin and pyridoxine. Proc Nutr Soc 58, 435440.
10. Powers, HJ, Weaver, LT, Austin, S et al. (1993) A proposed intestinal mechanism for the effect of riboflavin deficiency on iron loss in the rat. Br J Nutr 69, 553561.
11. Powers, HJ, Hill, MH, Mushtaq, S et al. (2011) Correcting a marginal riboflavin deficiency improves hematologic status in young women in the United Kingdom (RIBOFEM). Am J Clin Nutr 93, 12741284.
12. Powers, HJ (1995) Riboflavin-iron interactions with particular emphasis on the gastrointestinal tract. Proc Nutr Soc 54, 509517.
13. McCormick, DB (1989) Two interconnected B vitamins: riboflavin and pyridoxine. Physiol Rev 69, 11701198.
14. Rasmussen, KM, Barsa, PM & McCormick, DB (1979) Pyridoxamine (pyridoxine) 5′-phosphate oxidase activity in rat tissues during development of riboflavin or pyridoxine deficiency. Proc Soc Exp Biol Med 161, 527530.
15. Madigan, SM, Tracey, F, McNulty, H et al. (1998) Dietary intake and status of riboflavin and vitamin B6 and biochemical response to riboflavin supplementation in free living elderly people. Am J Clin Nutr 68, 389395.
16. Powers, HJ (2003) Riboflavin (vitamin B-2) and health. Am J Clin Nutr 93, 12741284.
17. Said, HM & Mohammadkhani, R (1993) uptake of riboflavin across the brush border membrane of rat intestine: regulation by dietary vitamin levels. Gastroenterology 105, 1294.
18. Sauberlich, HE, Skala, JH & Dowdy, RP (1974) Laboratory Tests for the Assessment of Nutritional Status. Boca Raton, FL: CRC Press.
19. McCormick, DB (1990) Riboflavin. In Present Knowledge in Nutrition, 6th ed., pp. 146. Washington, DC: International Life Sciences Institute.
20. Rivlin, RS (1991) Disorders of vitamin metabolism: deficiencies, metabolic abnormalities and excesses. In Cecil Textbook for Medicine, 19th ed., pp. 1170 [Wyngaarden, JH, Smith, LH Jr, Bennett, JC and Plum, F, editors]. Philadelphia: WB Saunders.
21. Pinto, JT, Huang, JP & Rivlin, RS (1987) Mechanisms underlying the different effects of ethanol upon the bioavailability of riboflavin and flavin adenine dinucleotide. J Clinc Invest 78, 1343.
22. Yuasa, H, Hirobe, M, Tomei, S et al. (2000) Carrier-mediated transport of riboflavin in the rat colon. Biopharm Drug Dispos 21, 7782.
23. Scientific Committee for Food (1993). Nutrient and Energy Intakes for European Community. (Opinion expressed on 11 December 1992). Thirty-first Series of Reports of the Scientific Committee for Food. Luxembourg: Commission of the European Communities.
24. Department of Health (1991) Dietary Reference Values for Food, Energy and Nutrients for the United Kingdom. London: HMSO.
25. Food and Nutrition Board, Institute of Medicine (1998) Dietary Reference Intakes for Thiamine, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin and Choline. Washington, DC: National Academy Press; 1998.
26. Scientific Committee for Food (2000). Nutrient and Energy Intakes for European Community. (Opinion Expressed on 22 November 2000). Thirty-third Series of Reports of the Scientific Committee for Food. Brussels: Commission of the European Communities.
27. Bates, B, Lennox, A, Bates, C et al. (2014) National Diet and Nutrition Survey: Results from Years 1–4 (combined) of the Rolling Programme (2008/2009–2011/12). London: Public Health England and the Food Standards Agency.
28. Allen, L, de Benoist, B, Dary, O et al. (2006) Guidelines on Food Fortification with Micronutrients. Geneva, Switzerland: World Health Organisation and Food and Agriculture Organisation of the United Nations.
29. McCormick, DB (1994) Riboflavin. In Modern Nutrition in Health and Disease, 8th ed., pp. 366 [Shils, ME, Olsen, JE and Shike, MM, editors]. Philadelphia.
30. Food and Nutrition Board. Institute of Medicine (2000) Riboflavin. In Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, biotin and Choline, pp. 87 [Pitkin, RM, editor]. Washington, DC: National Academy Press.
31. Rivlin, RS (1979) Effect of nutrient toxicities (excess) in animals and man: riboflavin. In Handbook of Nutrient and Foods, p. 25. [Recheigl, M, editor]. Boca Raton: CRC Press.
32. Cooperman, JM & Lopez, R (1984) Riboflavin. In Handbook of Vitamins: Nutritional, Biochemical and Clinical Aspects, p. 299 [Machlin, J, editor]. NY: Marcel Dekker.
33. Zempleni, J, Galloway, JR & McCormick, DB (1996) Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. Am J Clin Nutr 63, 5466.
34. Cimino, JA et al. (1987) Riboflavin metabolism in the hypothyroid human adult. Proc. Soc Exp Biol Med 184, 121.
35. Apeland, T, Mansoor, MA, Pentieva, K et al. (2003) Fasting and post methionine load concentrations of homocysteine, vitamin B2 and vitamin B6 in patients on antiepileptic drugs. Clinical Chemistry 49, 10051008.
36. Dutta, P, Pinto, JT & Rivlin, RS (1985) Antimalarial effects of riboflavin deficiency. Lancet 2, 1040.
37. Bates, CJ, Prentice, AM, Paul, AA et al. (1982) Riboflavin status in infants born in rural Gambia, and the effects of a weaning food supplement. Trans R Soc Trop Med Hyg 76, 253258.
38. Tan, KL, Chow, MT & Karim, SMM (1978) Effect of phototherapy on neonatal riboflavin status. J Pediatr 78, 780781.
39. Wacker, J, Fruhauf, J, Schulz, M et al. (2000) Riboflavin deficiency and preeclampsia. Obstet Gynecol 96, 3844.
40. Wu, XM, Yang, KX, Tang, XD et al. (2015) Folate metabolism gene polymorphisms MTHFR C677T and A1298C and risk for preeclampsia: a meta-analysis. J Assist Reprod Genet 32, 797805.
41. Belko, AZ, Obarzanek, E, Roach, R et al. (1984) Effects of aerobic exercise and weight loss on riboflavin requirements of moderately obese, marginally deficient young women. Am J Clin Nutr 40, 553561.
42. Soares, MJ, Satyanarayana, K, Bamji, MS et al. (1993) the effect of exercise on the riboflavin status of adult men. Br J Nutr 69, 541551.
43. Benton, D, Haller, J & Fordy, J (1997) The vitamin status of young British adults. Int J Vitam Nutr Res 67, 3440.
44. Hoey, L, McNulty, H & Strain, JJ (2009) Studies of biomarker responses to intervention with riboflavin: a systemic review. Am J Clin Nutr 89, 1960S1980S.
45. Pan, W-H, Chang, Y-P, Yeh, W-T et al. (2012) Co-occurrence of anemia, marginal vitamin B6, and folate status and depressive symptoms in older adults. J Geriatr Psychiatry Neurol 25, 170178.
46. Hill, MHE, Bradley, A, Mushtaq, S et al. (2009) Effects of methodological variation on assessment of riboflavin status using the erythrocyte glutathione reductase activation coefficient assay. Br J Nutr 102, 273278.
47. Clements, JE & Anderson, BB (1980) Glutathione reductase activity and pyridoxine (pyridoxamine) phosphate oxidase activity in the red cell. Biochim Biophys Acta 632, 159163.
48. Chastain, JL & McCormick, DB (1987) Flavin catabolites: identification and quantitation in human urine. Am J Clin Nutr 46, 830.
49. Horwitt, MK, Harvey, CC, Hills, OW et al. (1950) Correlation of urinary excretion of riboflavin with dietary intake and symptoms of ariboflavinosis. J Nutr 42, 247264.
50. Hustad, S, Ueland, P, Vollset, S et al. (2000) Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin Chem 46, 10651071.
51. Jacques, PF, Kalmbach, R, Bagley, PJ et al. (2002) The relationship between riboflavin and plasma total homocysteine in the Framingham offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene. J Nutr 132, 283288.
52. Hustad, S, McKinley, MC, McNulty, H et al. (2002) Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma and erythrocytes at baseline and after low-dose riboflavin supplementation. Clin Chem 48, 15711577.
53. Preziosai, P, Galan, P, Deheeger, M et al. (1999) breakfast type, daily nutrient intakes and vitamin and mineral status of French children, adolescents, and adults. J Am Coll Nutr 18, 171178.
54. Matrix, J, Aranda, P, Sanchez, C et al. (2003) Assessment of thiamin (vitamin B1) and riboflavin (vitamin B2) status in an adult Mediterranean population. Br J Nutr 90, 661666.
55. Troesch, B, Hoeft, B, McBurney, M et al. (2012) Dietary surveys indicate vitamin intakes below recommendations are common in representative Western countries. Br J Nutr 108, 692698.
56. ter Borg, S, Verlaan, S, Hemsworth, J et al. (2015) Micronutrient intakes and potential inadequacies of community-dwelling older adults: a systematic review. Br J Nutr 113, 11951206.
57. Shi, Z, Zhen, S, Wittert, GA et al. (2014) Inadequate riboflavin intake and anemia risk in a Chinese population: five-year follow up of the Jiangsu Nutrition Study. PLoS ONE 9, e88862.
58. Ministry of Health and Welfare Korea Centers for Disease Control and Prevention (2013) Korea Health Statistics 2010–2012: Korea National Health and Nutrition Examination Survey (KNHANES V-3). Osong, Korea: Korea Centers for Disease Control and Prevention.
59. Choi, JY, Kim, YN & Cho, YO (2015) Evaluation of riboflavin intakes and status of 20–64 year old adults in South Korea. Nutrients 7, 253264.
60. Brun, TA, Campbell, TC, Boreham, J et al. (1990) Urinary riboflavin excretion after a load test in rural China as a measure of possible riboflavin deficiency. Eur J Clin Nutr 44, 195206.
61. Abrams, SA, Mushi, A, Hilmers, DC et al. (2003) A multinutrient-fortified beverage enhances the nutritional status of children in Botswana. J Nutr 133, 18341840.
62. Boisvert, WA, Castaneda, C, Mendoza, I et al. (1993) Prevalence of riboflavin deficiency among Guatemalan elderly people and its relationship to milk intake. Am J Clin Nutr 58, 85.
63. Yang, FL, Liao, PC, Chen, YY et al. (2005) Prevalence of thiamin and riboflavin deficiency among the elderly in Taiwan. Asia Pac J Clin Nutr 14, 238243.
64. Whitfield, K, McCann, A, Karakochuk, C et al. (2015) High rates of riboflavin deficiency in women of childbearing age in Cambodia and Canada. J Nutr 145, 628633.
65. Frosst, P, Blom, HJ, Milos, R et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111113.
66. Guenther, BD, Sheppard, CA, Tran, P et al. (1999) The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocystaemia. Nat Struct Biol 6, 359365.
67. Yamada, K, Chen, Z, Rozen, R et al. (2001) Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 98, 1485314858.
68. Narisawa, K, Tamura, T, Tanno, K et al. (1968) Tetrahydro-folate-dependent enzyme activities of the rat liver in riboflavin deficiency. Tohoku J Exp Med 94, 417430.
69. Bates, CJ & Fuller, NJ (1986) The effect of riboflavin deficiency on methylenetetrahyfrofolate reductase (NADPH) (EC 1·5·1·20) and folate metabolism in the rat. Br J Nutr 55, 455464.
70. McNulty, H, Dowey le, RC, Strain, JJ, et al. (2006) Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C→T polymorphism. Circulation 113, 7480.
71. McNulty, H, McKinley, MC, Wilson, B et al. (2002) Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements. Am J Clin Nutr 76, 436441.
72. Garcia-Minguillan, CJ, Fernandez-Ballart, JD, Ceruelo, S et al. (2014) Riboflavin status the effects of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) polymorphisms on homocysteine. Genes Nutr 9, 435.
73. Wald, DS, Law, M & Morris, JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J 325, 1202.
74. Holmes, MV, Newcombe, P, Hubacek, JA et al. (2011) Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet 378, 584594.
75. Lewis, SJ, Ebrahim, S & Davey Smith, G (2005) Meta-analysis of MTHFR 677C→T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ 331, 1053.
76. Klerk, M, Verhoef, P, Clarke, R et al. (2002) MTHFR 677C→T polymorphism and risk of coronary heart disease – a meta-analysis. JAMA 288, 20232031.
77. Wald, DS, Morris, JK & Wald, NJ (2011) Reconciling the evidence on serum homocysteine and ischemic heart disease: a meta-analysis. PLoS ONE 6, e16473.
78. Clarke, R, Bennett, DA, Parish, S et al. (2012) Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. PLoS Med 9, e1001177.
79. Lim, SS, Vos, T & Flaxman, AD (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 22242260.
80. Lewington, S, Clarke, R, Qizilbash, N et al. (2002) Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 19031913.
81. Whelton, PK, He, J, Appel, LJ et al. (2002) Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 288, 18821888.
82. Luft, FC (2001) Twins in cardiovascular genetic research. Hypertension 37, 350356.
83. Mongeau, JG (1987) Heredity and blood-pressure in humans – an overview. Pediatr Nephrol 1, 6975.
84. Tomaszewski, M, Debiec, R, Braund, PS et al. (2010) Genetic architecture of ambulatory blood pressure in the general population insights from cardiovascular gene-centric array. Hypertension 56, 10691076.
85. Levy, D, Ehret, GB, Rice, K et al. (2009) Genome-wide association study of blood pressure and hypertension. Nat Genet 41, 677687.
86. Newton-Cheh, C, Johnson, T, Gateva, V et al. (2009) Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 41, 666676.
87. Takeuchi, F, Isono, M, Katsuya, T et al. (2010) Blood pressure and hypertension are associated with 7 Loci in the Japanese population. Circulation 121, 23022309.
88. Markan, S, Sachdeva, M, Sehrawat, BS et al. (2007) MTHFR 677 CT/MTHFR 1298 CC genotypes are associated with increased risk of hypertension in Indians. Mol Cell Biochem 302, 125131.
89. Liu, C, Li, H, Qi, Q et al. (2011) Common variants in or near FGF5, CYP17A1 and MTHFR genes are associated with blood pressure and hypertension in Chinese Hans. J Hypertens 29, 7075.
90. Flister, MJ, Tsaih, SW, O'Meara, CC et al. (2013) Identifying multiple causative genes at a single GWAS locus. Genome Res 23, 19962002.
91. Heux, S, Morin, F, Lea, RA et al. (2004) The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians. Hypertens Res 27, 663667.
92. Jiang, S, Hsu, YH, Xu, X et al. (2004) The C677T polymorphism of the methylenetetrahydrofolate reductase gene is associated with the level of decrease on diastolic blood pressure in essential hypertension patients treated by angiotensin-converting enzyme inhibitor. Thromb Res 113, 361369.
93. Nishio, H, Lee, H, Fujii, M et al. (1996) A common mutation in methylenetetrahydrofolate reductase gene among the Japanese population Japanese. J Hum Genet 41, 247251.
94. Bayramoglu, A, Kucuk, M, Guler, HI et al. (2015) Is there any genetic predisposition of MMP-9 gene C1562T and MTHFR gene C677T polymorphisms with essential hypertension? Cytotechnology 67, 115122.
95. Benes, P, Kankova, K, Muzik, J et al. (2001) Methylenetetrahydrolfolate reductase polymorphism, type II diabetes mellitus, coronary artery disease, and essential hypertension in the Czech population. Mol Genet Metab 73, 188195.
96. Inamoto, N, Katsuya, T, Kokubo, Y et al. (2003) Association of methlenetetrahydrolfolate reductase gene polymorphism with carortid atherosclerosis depending on smoking status in Japanese general population. Stroke 34, 16281633.
97. Guillen, M, Corella, O, Portoles, JI et al. (2001) Prevalence of the methylenetetrahydrofolate reductase 677C>T mutation in the Mediterranean Spanish population. Association with cardiovascular risk factors. Eur J Epidemiol 17, 255261.
98. Nakata, Y, Katsuya, T, Takami, S et al. (1998) Methylenetetrahydrofolate reductase gene polymorphism – relation to blood pressure and cerebrovascular disease. Am J Hypertens 11, 10191023.
99. Fowdar, YJ, Lason, MV, Szvetko, AL et al. (2012) Investigation of homocysteine-pathway-related variants in essential hypertension. Int J Hypertens 2012, 190923.
100. Rodriguez-Esparragon, F, Hernandez-Perera, O, Rodriguez-Perez, JC et al. (2003) The effect of methylenetetrahydrofolate reductase C677T common variant on hypertensive risk is not solely explained by increased plasma homocysteine values. Clin Exp Hypertens 25, 209220.
101. Reilly, R, McNulty, H, Ward, M et al. (2013) The MTHFR 677TT genotype and its interaction with related B-vitamins in hypertension. Ann Nutr Metab 63, 160.
102. Antoniades, C, Shirodaria, C, Warrick, N et al. (2006) 5-Methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and eNOS coupling. Circulation 114, 193201.
103. Antoniades, C, Shirodaria, C, Leeson, P et al. (2009) MTHFR 677 C→T polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 119, 25072515.
104. Bagley, PJ & Selhub, J (1998) A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci USA 95, 1321713220.
105. Strain, JJ, Hughes, CF, McNulty, H et al. (2015) Riboflavin lowers blood pressure: a review of a novel gene-nutrient interaction. Nutr Food Sci Res 2, 36.
106. Kaput, J (2008) Nutrigenomics research for personalised nutrition and medicine. Curr Opin Lipid 19, 111.
107. Ronteltap, A, van Trijp, H, Berezowska, A et al. (2013) Nutrigenomics-based personalised nutritonal advice: in search of a business model? Genes Nutr 8, 153163.
108. Makeeva, OA, Markova, VV, Roses, AD et al. (2010) An epidemiologic-based survey of public attitudes towards predictive genetic testing in Russia. Person Med 7, 291300.
109. Joost, H, Gibney, M, Cashman, K et al. (2007) Personalised nutrition: status and perspectives. Br J Nutr 98, 2631.
110. Cherkas, LF, Harris, JM, Levinson, E et al. (2010) A survey of UK public interest in internet-based personal genome testing. PLoS ONE 5, e13473.
111. Stewart-Knox, B, Bunting, B, Gilpin, S et al. (2008) Attitudes toward genetic testing and personalised nutrition in a representative sample of European consumers. Br J Nutr 101, 982989.
112. Aro, AR, Hakonen, A, Hietala, M et al. (1997) Acceptance of genetic testing in a general population: age, education and gender differences. Patient Educ Couns 32, 4149.
113. Bloss, CS, Schork, NJ & Topol, EJ (2011) Effect of direct-to-consumer genome wide profiling to assess disease risk. N Engl J Med 364, 524534.
114. McBride, CM, Koehly, LM, Sanderson, SC et al. (2010) The behavioral response to personalised genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behavours? Patient Educ Couns 31, 89103.
115. Norrgard, K (2008) DTC genetic testing for diabetes, breast cancer, heart disease and paternity. Nat Educ 1, 1.
116. Qian, X, Zhiagang, L, Miao, T et al. (2007) A meta-analysis of association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertension. Eur J Hum Genet 15, 12391245.
117. Niu, WQ, You, YG, Qi, Y et al. (2012) Strong association of methylenetetrahydrofolate reductase gene C677T polymorphism with hypertension and hypertension-in-pregnancy in Chinese: a meta-analysis. J Hum Hypertens 26, 259267.
118. Wu, YL, Hu, CY, Lu, SS et al. (2014) Associations between methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and essential hypertension: a systematic review and meta-analysis. Metabolism 63, 15031511.
119. Yang, KM, Jia, J, Mao, L et al. (2014) Methylenetetrahydrofolate reductase C677T gene polymorphism and essential hypertension: a meta-analysis of 10,415 subjects. Biomed Rep 2, 699708.
120. Bouwman, L, te Molder, H & Hiddink, G (2008) Patients evidence and genes: an exploration of GPs’ perspectives on gene-based personalised nutrition advice. Fam Pract 25, l116l122.
121. Bonter, K, Desjardins, C, Currier, N et al. (2011) Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family practice. BMJ Open 1, e000110.
122. Weir, M, Morin, K, Ries, N et al. (2010) Canadian health care professionals’ knowledge, attitudes and perceptions of nutritional genomics. Br J Nutr 104, 11121119.
123. Pirzadeh-Miller, S, Bellcross, C, Robinson, C et al. (2011) Direct-to-consumer genetic testing: helpful, harmful, or pure entertainment? Commun Oncol 8, 263268.
124. Cherkas, LF, Harris, JM, Levinson, E et al. (2010) A survey of UK public interest in internet-based personal genome testing. PLoS ONE 5, e13473.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Proceedings of the Nutrition Society
  • ISSN: 0029-6651
  • EISSN: 1475-2719
  • URL: /core/journals/proceedings-of-the-nutrition-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed